查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1668202

性病自我檢測市場 - 全球產業規模、佔有率、趨勢、機會和預測，按應用細分（CT/NG 檢測、梅毒檢測、HIV 檢測等）、按地區和競爭情況，2020-2030 年預測

STD Self-Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (CT/NG Testing, Syphilis Testing, HIV Testing, Others), By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 187 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球性病自我檢測市場價值為 12.1 億美元，預計到 2030 年將達到 18.6 億美元，預測期內的年複合成長率(CAGR) 為 7.43%。近年來，隨著人們性健康意識的增強、診斷技術的進步以及對隱私和傳統檢測方法的污名化擔憂的增加，性傳染病（STD）自我檢測市場出現了顯著成長。自我檢測試劑盒為個人提供了私人檢測的便利，減少了診斷和早期介入的障礙。由於這些試劑盒易於取得、易於使用，且能夠可靠地檢測愛滋病毒、衣原體、淋病、梅毒和人類乳突病毒（HPV）等感染，因此對這些試劑盒的需求正在成長。

市場概況
預測期 2026-2030
2024 年市場規模 12.1 億美元
2030 年市場規模 18.6 億美元
2025-2030 年複合年成長率 7.43%
成長最快的領域 CT/NG測試
最大的市場 北美洲

性病自我檢測市場的關鍵促進因素是全球性傳染病（STI）盛行率的上升。根據世界衛生組織 (WHO) 統計，全球 15 至 49 歲的人群中每天有超過一百萬人感染可治癒的性傳染感染，其中大多數是無症狀的。

數位健康解決方案和遠距醫療服務的日益普及進一步促進了自我檢測試劑盒的分發和使用，特別是在偏遠或服務不足的地區。此外，政府推動性健康教育的措施和提供自我檢測選項也對擴大市場起到了重要作用。由於人們對於到醫療機構進行性病檢測抱持偏見，因此人們越來越傾向於使用自我檢測試劑盒。許多人，尤其是年輕人和較保守的社會群體，更喜歡使用家庭診斷解決方案，而不是進行面對面的諮詢。消費者行為的轉變促使市場參與者開發創新、方便用戶使用且高度準確的自我測試產品。

診斷工具技術的進步大大提高了性病自檢試劑盒的準確性和可靠性。核酸擴增測試（NAAT）、橫向流動分析和基於智慧型手機的診斷工具等創新提高了家庭測試的效率。現在，許多現代自我測試套件都整合了行動應用程式，可以提供逐步指導、結果解釋和遠距醫療諮詢。這些進步不僅增強了使用者體驗，而且有助於及時診斷和治療，減少感染的傳播。

主要市場促進因素

性傳染病的盛行率不斷上升

主要市場挑戰

監理與合規挑戰

對準確性和可靠性的擔憂

主要市場趨勢

家庭診斷解決方案的採用率不斷提高

檢測試劑盒的技術進步

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：COVID-19 對全球 STD 自我檢測市場的影響

第5章：全球性病自我檢測市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依應用分類（CT/NG 檢測、梅毒檢測、HIV 檢測、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美性病自我檢測市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 墨西哥
    • 加拿大

第7章：歐洲性病自我檢測市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：亞太地區性病自我檢測市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章：南美性病自我檢測市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲性病自我檢測市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 應用程式啟動（如果有）
  • 最新動態

第 13 章：全球性病自我檢測市場：SWOT 分析

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章：競爭格局

  • OraSure Technologies, Inc.
  • Selfdiagnostics Deutschland GmbH
  • Wondfo BIOTECH CO., LTD.
  • bioLytical Laboratories Inc.
  • autotest VIH
  • Abbott Laboratories
  • Visby Medical Inc.
  • PrivaPath Diagnostics (LetsGetChecked)
  • NOWDiagnostics, Inc.

第 16 章：策略建議

第17章 關於出版商,免責事項

簡介目錄
Product Code: 27723

The global STD self-testing market was valued at USD 1.21 billion in 2024 and is projected to reach USD 1.86 billion by 2030, reflecting a compound annual growth rate (CAGR) of 7.43% during the forecast period. The market for self-testing of sexually transmitted diseases (STDs) has seen notable growth in recent years, driven by heightened awareness of sexual health, advancements in diagnostic technology, and increasing concerns regarding privacy and the stigma surrounding traditional testing methods. Self-testing kits offer individuals the convenience of private testing, reducing barriers to diagnosis and early intervention. The demand for these kits is growing due to their accessibility, ease of use, and reliability in detecting infections such as HIV, chlamydia, gonorrhea, syphilis, and human papillomavirus (HPV).

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.21 Billion
Market Size 2030USD 1.86 Billion
CAGR 2025-20307.43%
Fastest Growing SegmentCT/NG Testing
Largest MarketNorth America

A key driver of the STD self-testing market is the rising prevalence of sexually transmitted infections (STIs) globally. According to the World Health Organization (WHO), over one million curable STIs are contracted daily worldwide among individuals aged 15 to 49, with the majority of these being asymptomatic.

The increasing adoption of digital health solutions and telemedicine services has further facilitated the distribution and use of self-testing kits, particularly in remote or underserved areas. Additionally, government initiatives promoting sexual health education and the availability of self-testing options have been instrumental in expanding the market. The stigma associated with visiting healthcare facilities for STD testing has also led to a growing preference for self-testing kits. Many individuals, especially younger adults and those in more conservative societies, feel more comfortable using at-home diagnostic solutions rather than undergoing in-person consultations. This shift in consumer behavior has prompted market players to develop innovative, user-friendly, and highly accurate self-testing products.

Technological advancements in diagnostic tools have significantly enhanced the accuracy and reliability of STD self-testing kits. Innovations such as nucleic acid amplification tests (NAATs), lateral flow assays, and smartphone-based diagnostic tools have improved the efficiency of at-home testing. Many modern self-testing kits now integrate mobile applications that provide step-by-step guidance, results interpretation, and access to telehealth consultations. These advancements not only enhance the user experience but also contribute to timely diagnoses and treatment, reducing the spread of infections.

Key Market Drivers

Increasing Prevalence of Sexually Transmitted Diseases

The global market for STD self-testing is witnessing rapid growth, primarily fueled by the rising prevalence of STDs worldwide. Increased awareness of sexual health, the convenience of self-testing kits, and advancements in diagnostic technology are key factors contributing to market expansion. With governments and health organizations emphasizing early detection and prevention, demand for self-testing solutions has surged. The growing burden of STDs, including chlamydia, gonorrhea, syphilis, and HIV, highlights the need for accessible and discreet testing options. Self-testing kits provide a convenient, private, and efficient method for individuals to screen for infections without visiting a healthcare facility, making them an appealing alternative to traditional clinical testing.

Advancements in diagnostic technologies have also fueled the adoption of STD self-testing kits. Modern kits now incorporate features such as smartphone connectivity, rapid detection, and high accuracy, ensuring reliable results. Many kits are now designed to detect multiple infections in a single test, reducing the need for separate screenings and enhancing efficiency. The availability of easy-to-use, over-the-counter test kits has further strengthened the market by enabling individuals to take proactive measures for their sexual health.

Governments and non-governmental organizations (NGOs) are increasingly launching public health campaigns to raise awareness and combat the spread of STDs, further driving market growth. Various healthcare policies supporting self-testing, especially in regions with high STD prevalence, have improved access to these kits. For example, the U.S. Centers for Disease Control and Prevention (CDC) and the UK National Health Service (NHS) have promoted home-based testing to encourage early detection and reduce transmission rates.

The expansion of e-commerce and digital healthcare platforms has also played a significant role in making STD self-testing kits more accessible. Online platforms provide discreet purchasing options, addressing concerns about privacy and stigma. The integration of telemedicine with self-testing kits enhances consumer confidence by enabling virtual consultations with healthcare professionals for result interpretation and follow-up guidance.

Key Market Challenges

Regulatory and Compliance Challenges

A major challenge in the STD self-testing market is the complex regulatory landscape across various regions. Governments and health authorities have stringent guidelines to ensure the accuracy, reliability, and safety of self-testing kits. The variation in regulatory approvals complicates the standardization of products globally, leading to delays in market entry and increased compliance costs. Additionally, some countries do not yet recognize self-testing as a valid diagnostic method, limiting its accessibility and adoption.

Concerns Over Accuracy and Reliability

Another significant challenge is the accuracy and reliability of self-testing kits. While technological advancements have improved the sensitivity and specificity of these tests, there remains a risk of false positives or false negatives, which could result in misdiagnosis. This could lead to delayed treatment or unnecessary anxiety for users. Furthermore, some healthcare professionals express concerns about the lack of professional oversight, as users may misinterpret results without proper guidance, thereby reducing the effectiveness of self-testing.

Key Market Trends

Increased Adoption of At-Home Diagnostic Solutions

There has been a growing preference for at-home diagnostic solutions, particularly after the COVID-19 pandemic, which accelerated the trend of remote healthcare services. Consumers are increasingly comfortable using self-testing kits for various medical conditions, including STDs. The convenience of obtaining private results without the need for a clinic or laboratory visit has contributed to the rising demand for these products.

Technological Advancements in Testing Kits

Technological innovations have greatly improved the accuracy, reliability, and usability of STD self-testing kits. Modern kits incorporate advanced diagnostic technologies such as nucleic acid amplification tests (NAATs) and lateral flow assays, offering precise results. Furthermore, smartphone-based applications integrated with self-testing devices enable users to interpret results easily and receive guidance on the next steps.

Key Market Players

  • OraSure Technologies, Inc.
  • Selfdiagnostics Deutschland GmbH
  • Wondfo BIOTECH CO., LTD.
  • bioLytical Laboratories
  • autotest VIH Inc.
  • Abbott Laboratories
  • Visby Medical Inc.
  • PrivaPath Diagnostics (LetsGetChecked)
  • NOWDiagnostics Inc.

Report Scope

This report segments the global STD self-testing market and covers industry trends in detail:

By Application:

  • CT/NG Testing
  • Syphilis Testing
  • HIV Testing
  • Others

By Region:

  • North America (United States, Canada, Mexico)
  • Europe (France, United Kingdom, Italy, Germany, Spain)
  • Asia Pacific (China, India, Japan, Australia, South Korea)
  • South America (Brazil, Argentina, Colombia)
  • Middle East & Africa (South Africa, Saudi Arabia, UAE)

Competitive Landscape

The report includes detailed company profiles of major players in the global STD self-testing market.

Available Customizations:

The report offers customization options tailored to specific company needs, including additional analysis and profiling of up to five market players.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Applications
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global STD Self-Testing Market

5. Global STD Self-Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (CT/NG Testing, Syphilis Testing, HIV Testing, Others)
    • 5.2.2. By Region
    • 5.2.3. By Company (2024)
  • 5.3. Market Map

6. North America STD Self-Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States STD Self-Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
    • 6.3.2. Mexico STD Self-Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
    • 6.3.3. Canada STD Self-Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application

7. Europe STD Self-Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France STD Self-Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
    • 7.3.2. Germany STD Self-Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
    • 7.3.3. United Kingdom STD Self-Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
    • 7.3.4. Italy STD Self-Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
    • 7.3.5. Spain STD Self-Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application

8. Asia Pacific STD Self-Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China STD Self-Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
    • 8.3.2. India STD Self-Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
    • 8.3.3. South Korea STD Self-Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
    • 8.3.4. Japan STD Self-Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
    • 8.3.5. Australia STD Self-Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application

9. South America STD Self-Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil STD Self-Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
    • 9.3.2. Argentina STD Self-Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
    • 9.3.3. Colombia STD Self-Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application

10. Middle East and Africa STD Self-Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa STD Self-Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
    • 10.3.2. Saudi Arabia STD Self-Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
    • 10.3.3. UAE STD Self-Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Application Launches (If Any)
  • 12.3. Recent Developments

13. Global STD Self-Testing Market: SWOT Analysis

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. OraSure Technologies, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Selfdiagnostics Deutschland GmbH
  • 15.3. Wondfo BIOTECH CO., LTD.
  • 15.4. bioLytical Laboratories Inc.
  • 15.5. autotest VIH
  • 15.6. Abbott Laboratories
  • 15.7. Visby Medical Inc.
  • 15.8. PrivaPath Diagnostics (LetsGetChecked)
  • 15.9. NOWDiagnostics, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer